{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:41:04Z","timestamp":1791560464394,"version":"4.3.4"},"reference-count":343,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Type 1 diabetes (T1D) presents a persistent medical challenge, demanding innovative strategies for sustained glycemic control and enhanced patient well-being. Beta cells are specialized cells in the pancreas that produce insulin, a hormone that regulates blood sugar levels. When beta cells are damaged or destroyed, insulin production decreases, which leads to T1D. Allo Beta Cell Transplantation has emerged as a promising therapeutic avenue, with the goal of reinstating glucose regulation and insulin production in T1D patients. However, the path to success in this approach is fraught with complex immunological hurdles that demand rigorous exploration and resolution for enduring therapeutic efficacy. This exploration focuses on the distinct immunological characteristics inherent to Allo Beta Cell Transplantation. An understanding of these unique challenges is pivotal for the development of effective therapeutic interventions. The critical role of glucose regulation and insulin in immune activation is emphasized, with an emphasis on the intricate interplay between beta cells and immune cells. The transplantation site, particularly the liver, is examined in depth, highlighting its relevance in the context of complex immunological issues. Scrutiny extends to recipient and donor matching, including the utilization of multiple islet donors, while also considering the potential risk of autoimmune recurrence. Moreover, unanswered questions and persistent gaps in knowledge within the field are identified. These include the absence of robust evidence supporting immunosuppression treatments, the need for reliable methods to assess rejection and treatment protocols, the lack of validated biomarkers for monitoring beta cell loss, and the imperative need for improved beta cell imaging techniques. In addition, attention is drawn to emerging directions and transformative strategies in the field. This encompasses alternative immunosuppressive regimens and calcineurin-free immunoprotocols, as well as a reevaluation of induction therapy and recipient preconditioning methods. Innovative approaches targeting autoimmune recurrence, such as CAR Tregs and TCR Tregs, are explored, along with the potential of stem stealth cells, tissue engineering, and encapsulation to overcome the risk of graft rejection. In summary, this review provides a comprehensive overview of the inherent immunological obstacles associated with Allo Beta Cell Transplantation. It offers valuable insights into emerging strategies and directions that hold great promise for advancing the field and ultimately improving outcomes for individuals living with diabetes.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1323439","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:57:30Z","timestamp":1700737050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge"],"prefix":"10.3389","volume":"14","author":[{"given":"Rossana","family":"Caldara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tomajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Citro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raniero","family":"Chimienti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gremizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Catarinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tentori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Paloschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffella","family":"Melzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mercalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Magistretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"B1","volume-title":"The Treatment of Diabetes Mellitus: With Observations Upon the Disease Based Upon Thirteen Hundred Cases","author":"Joslin","year":"1917"},{"key":"B2","first-page":"141","article-title":"Pancreatic extracts in the treatment of diabetes mellitus","volume":"12","author":"Banting","year":"1922","journal-title":"Can Med Assoc J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-021-01737-3","article-title":"Felix dies natalis, insulin \u2026 Ceterum autem censeo \u201cBeta is better\u201d","volume":"58","author":"Piemonti","year":"2021","journal-title":"Acta Diabetol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-027635479355","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: A multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2018.10.002","article-title":"Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis","volume":"90","author":"Karageorgiou","year":"2019","journal-title":"Metabolism"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: A systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0436-y","article-title":"Artificial pancreas as an effective and safe alternative in patients with type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"9","author":"Dai","year":"2018","journal-title":"Diabetes Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2716","article-title":"Outcome measures for artificial pancreas clinical trials: A consensus report","volume":"39","author":"Maahs","year":"2016","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0003319719887655","article-title":"Fasting blood glucose and hba1c correlate with severity of coronary artery disease in elective Pci patients with Hba1c 5.7% to 6.4%","volume":"71","author":"Yang","year":"2020","journal-title":"Angiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.amepre.2014.02.002","article-title":"Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus","volume":"47","author":"Verdoia","year":"2014","journal-title":"Am J Prev Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2018.10.019","article-title":"Glucose variability and coronary artery disease","volume":"28","author":"Xia","year":"2019","journal-title":"Heart Lung Circ"},{"key":"B15","article-title":"Glycated haemoglobin is correlated with the severity of coronary artery disease independently of traditional risk factors in young patients","volume":"63","author":"Ayhan","year":"2012","journal-title":"Endokrynol Pol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"OC20","DOI":"10.7860\/jcdr\/2016\/22378.8525","article-title":"Glycated hemoglobin (Hba1c) correlation with severity of coronary artery disease in non-diabetic patients-a hospital based study from\u00a0North-Eastern India","volume":"10","author":"Dutta","year":"2016","journal-title":"J Clin Diagn research: JCDR"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000278","article-title":"Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: reykjavik prospective study and systematic review","volume":"7","author":"Sarwar","year":"2010","journal-title":"PloS Med"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2014.03.017","article-title":"Hemoglobin A1c in nondiabetic patients: an independent predictor of coronary artery disease and its severity","volume-title":"Mayo Clin Proc","author":"Garg","year":"2014"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.322.7277.15","article-title":"Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (Epic-norfolk)","volume":"322","author":"Khaw","year":"2001","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (Ukpds 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-6-200409210-00006","article-title":"Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk","volume":"141","author":"Khaw","year":"2004","journal-title":"Ann Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.8.968","article-title":"The relationship of glycemic exposure (Hba1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2010.03.002S1056-8727(10)00041-3","article-title":"The importance of glycemic control: how low should we go with hba1c? Start early, go safe, go low","volume":"25","author":"Benhalima","year":"2011","journal-title":"J Diabetes Complications"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12676","article-title":"Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison","volume":"32","author":"McKnight","year":"2015","journal-title":"Diabetes Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14069","article-title":"Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany\/Austria) registries","volume":"22","author":"Shah","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1d exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00737","article-title":"The australasian diabetes data network: first national audit of children and adolescents with type 1 diabetes","volume":"206","author":"Phelan","year":"2017","journal-title":"Med J Aust"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12372","article-title":"Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults","volume":"18","author":"Carlsen","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126427PONE-D-15-00548","article-title":"Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: A systematic review and meta-analysis of population based studies","volume":"10","author":"Edridge","year":"2015","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108522","article-title":"Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis","volume":"170","author":"Alwafi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11892-017-0965-1","article-title":"Reporting severe hypoglycemia in type 1 diabetes: facts and pitfalls","volume":"17","author":"Pedersen-Bjergaard","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4127jc.2012-","article-title":"Hypoglycemia and diabetes: A report of a workgroup of the American diabetes association and the endocrine society","volume":"98","author":"Seaquist","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.05.004","article-title":"Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes","volume":"130","author":"Khunti","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus","volume":"301","author":"Whitmer","year":"2009","journal-title":"Jama"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12000","article-title":"Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study","volume":"273","author":"Lin","year":"2013","journal-title":"J Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.6176","article-title":"Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus","volume":"173","author":"Yaffe","year":"2013","journal-title":"JAMA Internal Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4964-4","article-title":"Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: A randomised crossover trial","volume":"62","author":"Nilsson","year":"2019","journal-title":"Diabetologia"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05369-0","article-title":"Consequences of recurrent hypoglycaemia on brain function in diabetes","volume":"64","author":"McCrimmon","year":"2021","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ: Br Med J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0908dc14-0908","article-title":"Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the edinburgh type 2 diabetes study","volume":"37","author":"Bedenis","year":"2014","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc10-1371","article-title":"Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes","volume":"34","author":"Gim\u00e9nez","year":"2011","journal-title":"Diabetes Care"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0920","article-title":"Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: A cohort study","volume":"38","author":"Khunti","year":"2015","journal-title":"Diabetes Care"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.12.005","article-title":"Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics","volume":"103","author":"Hendrieckx","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-11-90","article-title":"Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: A time trade-off survey in five countries","volume":"11","author":"Evans","year":"2013","journal-title":"Health Qual Life outcomes"},{"key":"B45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11892-015-0660-z","article-title":"The detection and management of diabetes distress in people with type 1 diabetes","volume":"15","author":"Sturt","year":"2015","journal-title":"Curr Diabetes Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13912","article-title":"Increased proportion of time in hybrid closed-loop \u201cAuto mode\u201d Is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the minimed 670g insulin pump","volume":"22","author":"Duffus","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12971","article-title":"Real world hybrid closed-loop discontinuation: predictors and perceptions of youth discontinuing the 670g system in the first 6 months","volume":"21","author":"Messer","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e113635","DOI":"10.1371\/journal.pone.0113635PONE-D-14-37400","article-title":"A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality","volume":"9","author":"Lung","year":"2014","journal-title":"PloS One"},{"key":"B49","article-title":"Diabetes death rates among youths aged <\/= 19 years\u2013United States, 1968-2009","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2399","article-title":"Mortality in Type 1 Diabetes in the Dcct\/Edic Versus the General Population","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1170","article-title":"All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the allegheny county type 1 diabetes registry","volume":"33","author":"Secrest","year":"2010","journal-title":"Diabetes Care"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0120-4","article-title":"All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the Uk general practice research database, 1992\u20131999","volume":"49","author":"Soedamah-Muthu","year":"2006","journal-title":"Diabetologia"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3025-7","article-title":"Time trends in mortality rates in type 1 diabetes from 2002 to 2011","volume":"56","author":"J\u00f8rgensen","year":"2013","journal-title":"Diabetologia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3914-7","article-title":"Recent trends in life expectancy for people with type 1 diabetes in Sweden","volume":"59","author":"Petrie","year":"2016","journal-title":"Diabetologia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3857-4","article-title":"Life expectancy of type 1 diabetic patients during 1997\u20132010: A national Australian registry-based cohort study","volume":"59","author":"Huo","year":"2016","journal-title":"Diabetologia"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0824-8","article-title":"Early mortality in eurodiab population-based cohorts of type 1 diabetes diagnosed in childhood since 1989","volume":"50","author":"Patterson","year":"2007","journal-title":"Diabetologia"},{"key":"B57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010","volume":"313","author":"Livingstone","year":"2015","journal-title":"Jama"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.7.11.1627","article-title":"Allogeneic islet transplantation","volume":"7","author":"Marzorati","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1988dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16174","article-title":"Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes","volume":"21","author":"Markmann","year":"2021","journal-title":"Am J Transplant"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30078-0","article-title":"Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (Trimeco): A multicentre, randomised controlled trial","volume":"6","author":"Lablanche","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1480dc19-1480","article-title":"Targeting cxcr1\/2 does not improve insulin secretion after pancreatic islet transplantation: A phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes","volume":"43","author":"Maffi","year":"2020","journal-title":"Diabetes Care"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in beta-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","author":"Vantyghem","year":"2019","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0401","article-title":"Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: A prospective parallel-arm cohort study","volume":"42","author":"Vantyghem","year":"2019","journal-title":"Diabetes Care"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2115jc.2012-2115","article-title":"Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (Beta-score greater than 7) is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (Beta-score greater than 3)","volume":"97","author":"Vantyghem","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.624","article-title":"Reduced fear of hypoglycemia in successful islet transplantation","volume":"27","author":"Johnson","year":"2004","journal-title":"Diabetes Care"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01174.x","article-title":"Quality of life after islet transplantation","volume":"6","author":"Poggioli","year":"2006","journal-title":"Am J Transplant"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000280550.01028.8900007890-200709150-00017","article-title":"Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome","volume":"84","author":"Toso","year":"2007","journal-title":"Transplantation"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0741","article-title":"Restoration of hypoglycemia awareness after islet transplantation","volume":"31","author":"Leitao","year":"2008","journal-title":"Diabetes Care"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31818a7f4500007890-200811150-00002","article-title":"Improved long-term health-related quality of life after islet transplantation","volume":"86","author":"Tharavanij","year":"2008","journal-title":"Transplantation"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12265","article-title":"Comprehensive health assessment and five-yr follow-up of allogeneic islet transplant recipients","volume":"27","author":"Radosevich","year":"2013","journal-title":"Clin Transplant"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02731.xDME2731","article-title":"Quality of life after islet transplantation: data from the gragil 1 and 2 trials","volume":"26","author":"Benhamou","year":"2009","journal-title":"Diabetes Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318166a27b00007890-200803270-00005","article-title":"Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation","volume":"85","author":"Cure","year":"2008","journal-title":"Transplantation"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000160816.21799.F5","article-title":"Health-related quality of life after pancreatic islet transplantation: A longitudinal study","volume":"79","author":"Barshes","year":"2005","journal-title":"Transplantation"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31820437f3","article-title":"Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy","volume":"91","author":"Thompson","year":"2011","journal-title":"Transplantation"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.03.011","article-title":"The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy","volume":"37","author":"Lee","year":"2005","journal-title":"Transplant Proc"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318190b05200007890-200812270-00025","article-title":"A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes","volume":"86","author":"Warnock","year":"2008","journal-title":"Transplantation"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000208631.63235.6a00007890-200605150-00009","article-title":"Early Increase of Retinal Arterial and Venous Blood Flow Velocities at Color Doppler Imaging in Brittle Type 1 Diabetes after Islet Transplant Alone","volume":"81","author":"Venturini","year":"2006","journal-title":"Transplantation"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0206","article-title":"Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis","volume":"30","author":"Del Carro","year":"2007","journal-title":"Diabetes Care"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-032037\/6\/e141","article-title":"Improvement of electrophysiological neuropathy after islet transplantation for type 1 diabetes: A 5-year prospective study","volume":"37","author":"Vantyghem","year":"2014","journal-title":"Diabetes Care"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1663dc13-1663","article-title":"Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes","volume":"37","author":"D\u2019Addio","year":"2014","journal-title":"Diabetes Care"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0860-4","article-title":"Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: A 5 year single centre follow-up","volume":"51","author":"Gerber","year":"2008","journal-title":"Diabetologia"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01303.x","article-title":"Sequential kidney\/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol","volume":"6","author":"Toso","year":"2006","journal-title":"Am J Transplant"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000077339.20759.A3","article-title":"Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants","volume":"14","author":"Fiorina","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.6.1303","article-title":"Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation","volume":"28","author":"Fiorina","year":"2005","journal-title":"Diabetes Care"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1794","article-title":"Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy","volume":"30","author":"Maffi","year":"2007","journal-title":"Diabetes Care"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01573.x","article-title":"Changes in renal function after clinical islet transplantation: four-year observational study","volume":"7","author":"Senior","year":"2007","journal-title":"Am J Transplant"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000086","article-title":"Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy","volume":"98","author":"Gillard","year":"2014","journal-title":"Transplantation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.tp.0000265502.92321.ab00007890-200707150-00006","article-title":"The effect\u00a0of medical therapy and islet cell transplantation on diabetic nephropathy: an\u00a0interim report","volume":"84","author":"Fung","year":"2007","journal-title":"Transplantation"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31819279a800007890-200903150-","article-title":"Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management","volume":"87","author":"Leitao","year":"2009","journal-title":"Transplantation"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-814833-4.00034-4","article-title":"Islet vs pancreas transplantation in nonuremic patients with type 1 diabetes","author":"Zarinsefat","year":"2020","journal-title":"Transplantation Bioengineering Regeneration Endocrine Pancreas. Elsevier"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2018.01.009","article-title":"Pancreas transplantation for patients with type 1 and type 2 diabetes mellitus in the United States: A registry report","volume":"47","author":"Gruessner","year":"2018","journal-title":"Gastroenterol Clinics"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00064.x","article-title":"Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease","volume":"57","author":"Becker","year":"2000","journal-title":"Kidney Int"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50057","article-title":"Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure","volume":"41","author":"Reddy","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101150-00014","article-title":"The impact of simultaneous pancreas-kidney transplantation on long-term patient survival1","volume":"71","author":"Ojo","year":"2001","journal-title":"Transplantation"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32835c28c5","article-title":"Follow-up of secondary diabetic complications after pancreas transplantation","volume":"18","author":"Boggi","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32833552bc","article-title":"Impact of pancreas transplantation on type 1 diabetes-related complications","volume":"15","author":"Gremizzi","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000436","article-title":"Long-term diabetes complications after pancreas transplantation","volume":"22","author":"Jenssen","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"B100","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-814833-4.00011-3","article-title":"Chapter 11 - Pancreas after Kidney Transplantation","volume-title":"Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas","author":"Adler","year":"2020"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003627","article-title":"Treating type 1 diabetes by pancreas transplant alone: A cohort study on actual long-term (10 years) efficacy and safety","volume":"106","author":"Boggi","year":"2022","journal-title":"Transplantation"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000553","article-title":"Pancreas transplantation in type 2 diabetes: expanding the criteria","volume":"23","author":"Al-Qaoud","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12754","article-title":"Pancreas transplantation in older patients is safe, but patient selection is paramount","volume":"29","author":"Scalea","year":"2016","journal-title":"Transplant Int"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003628","article-title":"Pancreas transplantation alone: radical or rationale","volume":"106","author":"Stratta","year":"2021","journal-title":"Transplantation"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1259","article-title":"Production of pancreatic hormone\u2013expressing endocrine cells from human embryonic stem cells","volume":"24","author":"D\u2019Amour","year":"2006","journal-title":"Nat Biotechnol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.28","article-title":"Highly efficient differentiation of human es cells and ips cells into mature pancreatic insulin-producing cells","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M806597200","article-title":"Generation of insulin-secreting islet-like clusters from human skin fibroblasts","volume":"283","author":"Tateishi","year":"2008","journal-title":"J Biol Chem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1242\/dev.055236","article-title":"Stage-specific signaling through Tgf\u03b2 Family members and Wnt regulates patterning and pancreatic specification of human pluripotent stem cells","volume":"138","author":"Nostro","year":"2011","journal-title":"Development"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400709111","article-title":"Differentiated human stem cells resemble fetal, not adult, B Cells","volume":"111","author":"Hrvatin","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic B Cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201591058","article-title":"Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro","volume":"34","author":"Russ","year":"2015","journal-title":"EMBO J"},{"key":"B113","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1152\/physiol.00026.2018","article-title":"Pluripotent stem cell-derived pancreatic progenitors and B-like cells for type 1 diabetes treatment","volume":"33","author":"Sambathkumar","year":"2018","journal-title":"Physiology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0058","article-title":"Concise review: manufacturing of pancreatic endoderm cells for clinical trials in type 1 diabetes","volume":"4","author":"Schulz","year":"2015","journal-title":"Stem Cells Trans Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0079","article-title":"Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo","volume":"4","author":"Agulnick","year":"2015","journal-title":"Stem Cells Trans Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","article-title":"Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes","volume":"28","author":"Ramzy","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B117","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.xcrm.2021.100466","article-title":"Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device","volume":"2","author":"Shapiro","year":"2021","journal-title":"Cell Rep Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.2337\/db23-836-P","article-title":"836-P: glucose-dependent insulin production and insulin-independence in type 1 diabetes from stem cell\u2013derived, fully differentiated islet cells\u2014Updated data from the Vx-880 clinical trial","volume":"72","author":"Reichman","year":"2023","journal-title":"Diabetes"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.05.004","article-title":"Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (Sin), the Italian Society for Organ Transplantation (Sito) and the Italian Diabetes Society (Sid)","volume":"30","author":"Conte","year":"2020","journal-title":"Nutrition Metab Cardiovasc Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-1-1","article-title":"Early peri-operative hyperglycaemia and renal allograft rejection in patients withoutdiabetes","volume":"1","author":"Thomas","year":"2000","journal-title":"BMC Nephrol"},{"key":"B121","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2004.10.067","article-title":"Random blood glucose measurements and survival in nondiabetic renal transplant recipients","volume-title":"Transplantation Proceedings","author":"Tutone","year":"2004"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181c3c2ff","article-title":"Post-transplant hyperglycemia is associated with increased risk of liver allograft rejection","volume":"89","author":"Wallia","year":"2010","journal-title":"Transplantation"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011944400908","article-title":"Variations of the effect of insulin on neutrophil respiratory burst. The role of tyrosine kinases and phosphatases","volume":"66","author":"Safronova","year":"2001","journal-title":". Biochem (Moscow)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1677\/JOE-08-0028","article-title":"Insulin-like growth factor-1 delays fas-mediated apoptosis in human neutrophils through the phosphatidylinositol-3 kinase pathway","volume":"199","author":"Himpe","year":"2008","journal-title":"J Endocrinol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1159\/000479904","article-title":"Insulin influences lps-induced tnf-B and il-6 release through distinct pathways in mouse macrophages from different compartments","volume":"42","author":"Tessaro","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3AB0120-019RR","article-title":"Insulin acutely activates metabolism of primary human monocytes and promotes a proinflammatory phenotype","volume":"110","author":"Ratter","year":"2021","journal-title":"J leukocyte Biol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00633","article-title":"Insulin modulates cytokine release, collagen and mucus secretion in lung remodeling of allergic diabetic mice","volume":"8","author":"Ferreira","year":"2017","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.03.005","article-title":"Insulin enhances dendritic cell maturation and scavenger receptor-mediated uptake of oxidised low-density lipoprotein","volume":"29","author":"Lu","year":"2015","journal-title":"J Diabetes its Complications"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.01.005","article-title":"Insulin-like growth factor 1 supports a pulmonary niche that promotes type 3 innate lymphoid cell development in newborn lungs","volume":"52","author":"Oherle","year":"2020","journal-title":"Immunity"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601011","article-title":"The insulin receptor plays a critical role in T cell function and adaptive immunity","volume":"198","author":"Fischer","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/274062a0","article-title":"Specific insulin binding site on T and B lymphocytes as a marker of cell activation","volume":"274","author":"Helderman","year":"1978","journal-title":"Nature"},{"key":"B132","article-title":"Insulin modulates the interleukin 2 responsiveness of T lymphocytes","volume":"3","author":"DeBenedette","year":"1990","journal-title":"Regional Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.138.7.2100","article-title":"Chemotactic activity of porcine insulin for human T lymphocytes in vitro","volume":"138","author":"Berman","year":"1987","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.3390\/ijms20194962","article-title":"Pharmacological targeting of glut1 to control autoreactive T cell responses","volume":"20","author":"Di Dedda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.013","article-title":"Insulin-like growth factors are key regulators of T helper 17 regulatory T cell balance in autoimmunity","volume":"52","author":"DiToro","year":"2020","journal-title":"Immunity"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e20191542","DOI":"10.1084\/jem.20191542","article-title":"T reg\u2013specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome","volume":"217","author":"Wu","year":"2020","journal-title":"J Exp Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0209","article-title":"Hyperglycemia and not hyperinsulinemia mediates diabetes-induced memory cd8 T-cell dysfunction","volume":"71","author":"Kavazovi\u0107","year":"2022","journal-title":"Diabetes"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.9.5516","article-title":"Insulin-like growth factor-1 controls type 2 T cell-independent B cell response","volume":"174","author":"Baudler","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/TP.0b013e3181aa7cc2","article-title":"Type 2 diabetes mellitus phenotype and graft survival after islet transplantation","volume":"88","author":"Leit\u00e3o","year":"2009","journal-title":"Transplantation"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-06034-y","article-title":"Homa-ir and the matsuda index as predictors of progression to type 1 diabetes in autoantibody-positive relatives","author":"Petrelli","year":"2023","journal-title":"Diabetologia"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"key":"B142","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","article-title":"Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections","volume":"24","author":"Gonz\u00e1lez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e0220577","DOI":"10.1371\/journal.pone.0220577","article-title":"Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages","volume":"14","author":"Morey","year":"2019","journal-title":"PloS One"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/bab.1938","article-title":"Harmful effects of high amounts of glucose on the immune system: an updated review","volume":"68","author":"Shomali","year":"2021","journal-title":"Biotechnol Appl Biochem"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1089\/met.2016.29006.pah","article-title":"Hyperglycemia induces toll-like receptor activity through increased oxidative stress","volume":"14","author":"Pahwa","year":"2016","journal-title":"Metab syndrome related Disord"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.607473","article-title":"Chronic hyperglycemia drives functional impairment of lymphocytes in diabetic ins\u00a0C94y transgenic pigs","volume":"11","author":"Giese","year":"2021","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"BSR20171079","DOI":"10.1042\/BSR20171079","article-title":"Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by cd8+ T cells in vivo","volume":"37","author":"Recino","year":"2017","journal-title":"Bioscience Rep"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.29074\/ascls.2018000331","article-title":"The role of hyperglycemia in cd4 T cell survival and differentiation","author":"Iwai","year":"2018","journal-title":"Am Soc Clin Lab Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000250659.24286.43","article-title":"Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: implication for mouse model","volume":"83","author":"Melzi","year":"2007","journal-title":"Transplantation"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756548","article-title":"Tse HM. Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis","volume":"12","author":"Toren","year":"2021","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.molmet.2023.101809","article-title":"The beta cell-immune cell interface in type 1 diabetes (T1d)","volume":"78","author":"James","year":"2023","journal-title":"Mol Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0871","article-title":"Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors","volume":"38","author":"Oram","year":"2015","journal-title":"Diabetes Care"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.08.013","article-title":"Persistence of pancreatic insulin mrna expression and proinsulin protein in type 1 diabetes pancreata","volume":"26","author":"Wasserfall","year":"2017","journal-title":"Cell Metab"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1642-y","article-title":"Dimorphic histopathology of long-standing childhood-onset diabetes","volume":"53","author":"Gianani","year":"2010","journal-title":"Diabetologia"},{"key":"B155","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.1038\/ncomms11756","article-title":"Human islets contain four distinct subtypes of B Cells","volume":"7","author":"Dorrell","year":"2016","journal-title":"Nat Commun"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.03.008","article-title":"Epigenetic dosage identifies two major and functionally distinct B Cell subtypes","volume":"35","author":"Dror","year":"2023","journal-title":"Cell\u00a0Metab"},{"key":"B157","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cmet.2016.06.020","article-title":"Beta cell hubs dictate pancreatic islet responses to glucose","volume":"24","author":"Johnston","year":"2016","journal-title":"Cell Metab"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0075-2","article-title":"Leader B-cells coordinate Ca2+ Dynamics across pancreatic islets in vivo","volume":"1","author":"Salem","year":"2019","journal-title":"Nat\u00a0Metab"},{"key":"B159","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-021-00568-0","article-title":"The physiological role of B-cell heterogeneity in pancreatic islet function","volume":"18","author":"Benninger","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00067","article-title":"B Cell er stress and the implications for immunogenicity in type 1 diabetes","volume":"3","author":"Marr\u00e9","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.690379","article-title":"Oxidative stress leads to B-cell dysfunction through loss of B-cell identity","volume":"12","author":"Leenders","year":"2021","journal-title":"Front\u00a0Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1530\/JME-15-0232","article-title":"Oxidative and endoplasmic reticulum stress in B-cell dysfunction in diabetes","volume":"56","author":"Hasnain","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-B Mediates human beta cell Hla class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.2337\/dbi17-0030","article-title":"Immune recognition of B-cells: neoepitopes as key players in the loss of tolerance","volume":"67","author":"James","year":"2018","journal-title":"Diabetes"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667989","article-title":"Neoepitopes in type 1 diabetes: etiological insights, biomarkers and therapeutic targets","volume":"12","author":"Rodriguez-Calvo","year":"2021","journal-title":"Front Immunol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.2337\/dbi19-0022","article-title":"T-cell epitopes and neo-epitopes in type 1 diabetes: A comprehensive update and reappraisal","volume":"69","author":"James","year":"2020","journal-title":"Diabetes"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.07.007","article-title":"Conventional and neo-antigenic peptides presented by B Cells are targeted by circulating na\u00efve Cd8+ T cells in type 1 diabetic and healthy donors","volume":"28","author":"Gonzalez-Duque","year":"2018","journal-title":"Cell Metab"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp474","article-title":"Mda5 and Ptpn2, two candidate genes for type 1 diabetes, modify pancreatic B-cell responses to the viral by-product double-stranded rna","volume":"19","author":"Colli","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0362","article-title":"Tyk2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic B-cells","volume":"64","author":"Marroqui","year":"2015","journal-title":"Diabetes"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0758","article-title":"Ptpn2, a candidate gene for type 1 diabetes, modulates pancreatic B-cell apoptosis via regulation of the Bh3-only protein bim","volume":"60","author":"Santin","year":"2011","journal-title":"Diabetes"},{"key":"B171","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1038\/s41467-022-34069-z","article-title":"The type 1 diabetes gene tyk2 regulates B-cell development and its responses to interferon-B","volume":"13","author":"Chandra","year":"2022","journal-title":"Nat Commun"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00125-023-05908-5","article-title":"Inhibition of the type 1 diabetes candidate gene Ptpn2 aggravates Tnf-B-induced human beta cell dysfunction and death","volume":"66","author":"Roca-Rivada","year":"2023","journal-title":"Diabetologia"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201803_14588","article-title":"Intramuscular islet allotransplantation in type 1 diabetes mellitus","volume":"22","author":"Bertuzzi","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0205","article-title":"Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets","volume":"59","author":"Christoffersson","year":"2010","journal-title":"Diabetes"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1177\/0963689718798627","article-title":"Omental pouch technique for combined site islet autotransplantation following total pancreatectomy","volume":"27","author":"Stice","year":"2018","journal-title":"Cell Transplant"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0465","article-title":"Autologous pancreatic islet transplantation in human bone marrow","volume":"62","author":"Maffi","year":"2013","journal-title":"Diabetes"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002416","article-title":"Islet allotransplantation in the bone marrow of patients with type 1 diabetes: A pilot randomized trial","volume":"103","author":"Maffi","year":"2019","journal-title":"Transplantation"},{"key":"B178","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2018.02.138","article-title":"Endoscopic islet autotransplantation into gastric submucosa\u20141000-day follow-up of patients","volume-title":"Transplantation Proceedings","author":"Wszola","year":"2018"},{"key":"B179","doi-asserted-by":"crossref","DOI":"10.1016\/S0041-1345(97)01327-4","article-title":"Intraportal vs kidney subcapsular site for human pancreatic islet transplantation","volume-title":"Transplantation Proceedings","author":"Jindal","year":"1998"},{"key":"B180","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/096368970000900103","article-title":"The risks of total pancreatectomy and splenic islet autotransplantation","volume":"9","author":"White","year":"2000","journal-title":"Cell Transplant"},{"key":"B181","first-page":"e2120","article-title":"Clinical intraocular islet transplantation is not a number issue","volume":"4","author":"Shishido","year":"2016","journal-title":"CellR4\u2013repair replacement regeneration reprogramming"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001462","article-title":"Transplant site influences the immune response after islet transplantation: bone marrow versus liver","volume":"101","author":"Cantarelli","year":"2017","journal-title":"Transplantation"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/BF00264907","article-title":"Demonstration of donor specific unresponsiveness in rat islet allografts: importance of transplant site for induction by cyclosporin a and maintenance","volume":"32","author":"Kamei","year":"1989","journal-title":"Diabetologia"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.3.372","article-title":"Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts","volume":"46","author":"Guan","year":"1997","journal-title":"Diabetes"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1620","article-title":"Restoration of glucose counterregulation by islet transplantation in long-standing type 1 diabetes","volume":"64","author":"Rickels","year":"2015","journal-title":"Diabetes"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.1.23","article-title":"Defective glucagon secretion during sustained hypoglycemia following successful islet allo-and autotransplantation in humans","volume":"46","author":"Kendall","year":"1997","journal-title":"Diabetes"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181bc06b0","article-title":"Histologic graft assessment after clinical islet transplantation","volume":"88","author":"Toso","year":"2009","journal-title":"Transplantation"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)12020-4","article-title":"Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation","volume":"360","author":"Moberg","year":"2002","journal-title":"Lancet"},{"key":"B189","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/diabetes.51.1.55","article-title":"Human pancreatic islets produce and secrete Mcp-1\/Ccl2: relevance in human islet transplantation","volume":"51","author":"Piemonti","year":"2002","journal-title":"Diabetes"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3727\/096368910X514639","article-title":"Role of ccl2\/mcp-1 in islet transplantation","volume":"19","author":"Melzi","year":"2010","journal-title":"Cell Transplant"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.10.2883","article-title":"Fasting plasma leptin, monocyte chemoattracting protein-1 (Mcp-1\/ccl2) and B-tumor necrosis factor receptor 2 (B-tnfr-2) concentrations in glucose tolerant and intolerant women","volume":"26","author":"Piemonti","year":"2003","journal-title":"Impact Cardiovasc Mortality. Diabetes Care"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.3.489","article-title":"Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site","volume":"50","author":"Carlsson","year":"2001","journal-title":"Diabetes"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"New Engl J Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1387","article-title":"Lipotoxicity and decreased islet graft survival","volume":"33","author":"LEITao","year":"2010","journal-title":"Diabetes Care"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12919","article-title":"Intraportal islet transplantation: the impact of the liver microenvironment","volume":"30","author":"Delaune","year":"2017","journal-title":"Transplant Int"},{"key":"B196","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12775\/JEHS.2023.32.01.004","article-title":"Pancreatic islet transplantation in patients suffering from type 1 diabetes-indications, methods, possible risks and future directions: A literature review","volume":"32","author":"Wolanin","year":"2023","journal-title":"J Education Health Sport"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-814833-4.00065-4","article-title":"Alternative transplantation sites for islet transplantation","author":"Pellegrini","year":"2020","journal-title":"Transplantation Bioengineering Regeneration Endocrine Pancreas. Elsevier"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-017-0901-4","article-title":"Immunological issues after stem cell-based B Cell replacement","volume":"17","author":"Sordi","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1258db12-1258","article-title":"Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"key":"B200","first-page":"1969","article-title":"Matching in pancreas transplantation-a registry analysis","volume-title":"Transplantation Proceedings","author":"Gruessner","year":"2001"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1082","article-title":"Impact of hla matching on the outcome of simultaneous pancreas\u2013kidney transplantation","volume":"20","author":"Berney","year":"2005","journal-title":"Nephrol Dialysis Transplant"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13734","article-title":"Hla-a,-B,-C,-Dr, and-Dq matching in pancreas transplantation: effect on graft rejection and survival","volume":"16","author":"Rudolph","year":"2016","journal-title":"Am J Transplant"},{"key":"B203","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2005.05.023","article-title":"Effect of Hla Matching in Simultaneous Pancreas\u2013Kidney Transplantation","volume-title":"Transplantation Proceedings","author":"Malaise","year":"2005"},{"key":"B204","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5414\/CNP57027","article-title":"Hla matching for simultaneous pancreas-kidney transplantation in the United States: A multivariable analysis of the unos data","volume":"57","author":"Mancini","year":"2002","journal-title":"Clin Nephrol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1111\/tri.14138","article-title":"Association of human leukocyte antigen mismatches between donor-recipient and donor-donor in pancreas after kidney transplant recipients","volume":"34","author":"Parajuli","year":"2021","journal-title":"Transplant Int"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1110544","article-title":"Matching for hla-dr excluding diabetogenic Hla-Dr3 and Hla-Dr4 predicts insulin independence after pancreatic islet transplantation","volume":"14","author":"Ballou","year":"2023","journal-title":"Front Immunol"},{"key":"B207","doi-asserted-by":"publisher","first-page":"9636897231166529","DOI":"10.1177\/09636897231166529","article-title":"Hla-B Matching Prolongs Allograft Survival in Islet Cell Transplantation","volume":"32","author":"Lemos","year":"2023","journal-title":"Cell\u00a0Transplant"},{"key":"B208","doi-asserted-by":"publisher","first-page":"09636897231166529","DOI":"10.1177\/09636897231166529","article-title":"Hla-B matching prolongs allograft survival in islet cell transplantation","volume":"32","author":"Lemos","year":"2023","journal-title":"Cell Transplant"},{"key":"B209","article-title":"Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes","volume":"97","author":"Sutherland","year":"1984","journal-title":"Trans Assoc Am Physicians"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-015-0691-5","article-title":"Lessons from pancreas transplantation in type 1 diabetes: recurrence of islet autoimmunity","volume":"15","author":"Burke","year":"2015","journal-title":"Curr Diabetes Rep"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.2337\/diab.38.1.S82","article-title":"Islet cell autoimmunity in type I diabetic patients after hla-mismatched pancreas transplantation","volume":"38","author":"Bosi","year":"1989","journal-title":"Diabetes"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199807150-00022","article-title":"Recurrence of immunological markers for type 1 (Insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation","volume":"66","author":"Esmatjes","year":"1998","journal-title":"Transplantation"},{"key":"B213","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00007890-200001150-00018","article-title":"Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation","volume":"69","author":"Thivolet","year":"2000","journal-title":"Transplantation"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.2.218","article-title":"Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes","volume":"49","author":"Braghi","year":"2000","journal-title":"Diabetes"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03844.x","article-title":"Recurrence of type 1 diabetes after simultaneous pancreas\u2013kidney transplantation in\u00a0the absence of gad and ia-2 autoantibodies","volume":"12","author":"Assalino","year":"2012","journal-title":"Am J Transplant"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31822ae65f","article-title":"Zinc transporter 8 autoantibodies increase the predictive value of islet autoantibodies for function loss of technically successful solitary pancreas transplant","volume":"92","author":"Occhipinti","year":"2011","journal-title":"Transplantation"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc061530","article-title":"Autoimmunity after Islet-Cell Allotransplantation","volume":"355","author":"Sharma","year":"2006","journal-title":"N Engl J Med"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199604270-00027","article-title":"Evidence of recurrent autoimmunity in\u00a0human allogeneic islet transplantation","volume":"61","author":"Stegall","year":"1996","journal-title":"Transplantation"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15322","article-title":"Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation","volume":"19","author":"Korutla","year":"2019","journal-title":"Am J Transplant"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.01.001","article-title":"The prognostic significance of glutamic acid decarboxylase antibodies in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplantation","volume":"45","author":"Kizilgul","year":"2019","journal-title":"Diabetes Metab"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.11.1907","article-title":"Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative iddm recipients of intrahepatic islet allografts","volume":"46","author":"Jaeger","year":"1997","journal-title":"Diabetes"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.11.2464","article-title":"Autoantibody response to islet transplantation in type 1 diabetes","volume":"50","author":"Bosi","year":"2001","journal-title":"Diabetes"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.3.484","article-title":"Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients","volume":"48","author":"Roep","year":"1999","journal-title":"Diabetes"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1486db09-1486","article-title":"Simultaneous detection of circulating autoreactive Cd8+ T-cells specific for different islet cell-associated epitopes using combinatorial mhc multimers","volume":"59","author":"Velthuis","year":"2010","journal-title":"Diabetes"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35197","article-title":"Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells","volume":"118","author":"Monti","year":"2008","journal-title":"J Clin Invest"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001276","article-title":"Il-7 mediated homeostatic expansion of human Cd4+ Cd25+ Foxp3+ Regulatory T cells after depletion with anti-Cd25 monoclonal antibody","volume":"100","author":"Vignali","year":"2016","journal-title":"Transplantation"},{"key":"B227","doi-asserted-by":"publisher","first-page":"217934","DOI":"10.1155\/2013\/217934","article-title":"Homeostatic T Cell Proliferation after Islet Transplantation","volume":"2013","author":"Monti","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78555-X","article-title":"Transfer of diabetes type 1 by bone-marrow transplantation","volume":"351","author":"Lampeter","year":"1998","journal-title":"Lancet"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13216","article-title":"Development of autoimmune-mediated B Cell failure after total pancreatectomy with autologous islet transplantation","volume":"15","author":"Bellin","year":"2015","journal-title":"Am J Transplant"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.21926\/obm.transplant.1803014","article-title":"Autoimmunity in autologous islet transplantation","volume":"2","author":"Ali","year":"2018","journal-title":"OBM Transplant"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"New Engl J Med"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000977","article-title":"Anti-inflammatory approach with early double cytokine blockade (Il-1B and Tnf-B) is safe and facilitates engraftment in\u00a0islet allotransplantation","volume":"6","author":"Onaca","year":"2020","journal-title":"Transplant direct"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.4.515","article-title":"Insulin Independence after Islet Transplantation into Type I Diabetic Patient","volume":"39","author":"Scharp","year":"1990","journal-title":"Diabetes"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.05.035","article-title":"Diagnosis and treatment of allograft rejection in islet transplantation","volume":"23","author":"Landstra","year":"2023","journal-title":"Am J Transplant"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.04.008","article-title":"Beyond the biopsy: is it time to change the gold standard for rejection diagnosis in clinical decision-making and scientific discovery","volume":"41","author":"Nakano","year":"2022","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0172","article-title":"Evidence for allograft rejection in an islet transplant recipient and effect on B-cell secretory capacity","volume":"92","author":"Rickels","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02711.x","article-title":"Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and Iv immunoglobulin therapy","volume":"9","author":"Kessler","year":"2009","journal-title":"Am J Transplant"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31823f7fb2","article-title":"Rescue of a\u00a0pancreatic islet graft after steroid therapy","volume":"93","author":"Moreau","year":"2012","journal-title":"Transplantation"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004058","article-title":"International survey of clinical monitoring practices in pancreas and islet transplantation","volume":"106","author":"Ward","year":"2022","journal-title":"Transplantation"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13138","article-title":"Defining outcomes for B-cell replacement therapy in the treatment of diabetes: A consensus report on the igls criteria from the Ipita\/Epita opinion leaders workshop","volume":"31","author":"Rickels","year":"2018","journal-title":"Transplant Int"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13407","article-title":"De novo donor-specific hla antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes","volume":"15","author":"Brooks","year":"2015","journal-title":"Am J Transplant"},{"key":"B242","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1038\/s41598-022-16782-3","article-title":"The challenge of Hla donor specific antibodies in the management of pancreatic islet transplantation: an illustrative case-series","volume":"12","author":"Maanaoui","year":"2022","journal-title":"Sci Rep"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13936","article-title":"Anti-donor Hla antibody response after pancreatic islet grafting: characteristics, risk factors, and impact on graft function","volume":"17","author":"Pouliquen","year":"2017","journal-title":"Am J Transplant"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.3727\/096368916X691673","article-title":"Immunogenicity of anti-Hla antibodies in pancreas and islet transplantation","volume":"25","author":"Chaigne","year":"2016","journal-title":"Cell\u00a0Transplant"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1172\/jci93542","article-title":"Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection","volume":"128","author":"Chen","year":"2018","journal-title":"J Clin Invest"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.3.557","article-title":"Molecular detection of circulating B-cells after islet transplantation","volume":"51","author":"Ritz-Laser","year":"2002","journal-title":"Diabetes"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01373.x","article-title":"Detection of insulin mrna in the peripheral blood after human islet transplantion predicts deterioration of metabolic control","volume":"6","author":"Berney","year":"2006","journal-title":"Am J Transplant"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1216","article-title":"Plasma Gad65, a marker for early B-cell loss after intraportal islet cell transplantation in diabetic patients","volume":"100","author":"Ling","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B249","article-title":"Circulating Mir-375 levels after islet transplantation in humans: A biomarker for ongoing beta cell injury","volume":"1","author":"Piemonti","year":"2013","journal-title":"CellR4"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000625","article-title":"Evaluation of microrna375 as a novel biomarker for graft damage in clinical islet transplantation","volume":"99","author":"Kanak","year":"2015","journal-title":"Transplantation"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14054","article-title":"Unmethylated insulin DNA is elevated after total pancreatectomy with islet autotransplantation: assessment of a novel beta cell marker","volume":"17","author":"Bellin","year":"2017","journal-title":"Am J Transplant"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002083","article-title":"Beta cell death by cell-free DNA and outcome after clinical islet transplantation","volume":"102","author":"Gala-Lopez","year":"2018","journal-title":"Transplantation"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.714348","article-title":"Non-invasive beta-cell imaging: visualization, quantification, and beyond","volume":"12","author":"Murakami","year":"2021","journal-title":"Front Endocrinol"},{"key":"B254","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/biomedicines9121824","article-title":"The current state of beta-cell-mass pet imaging for diabetes research and therapies","volume":"9","author":"Cheung","year":"2021","journal-title":"Biomedicines"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(06)72809-9","article-title":"Immunosuppressive drug-induced diabetes","volume":"32","author":"Penfornis","year":"2006","journal-title":"Diabetes Metab"},{"key":"B256","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001379","article-title":"Impact of Immune-Modulatory Drugs on Regulatory T Cell","volume":"100","author":"Furukawa","year":"2016","journal-title":"Transplantation"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune reconstitution following rabbit antithymocyte globulin","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02078.x","article-title":"Homeostatic repopulation by Cd28\u2013 Cd8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression","volume":"8","author":"Trzonkowski","year":"2008","journal-title":"Am J Transplant"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02825.x","article-title":"Disengaging the il-2 receptor with daclizumab enhances Il-7\u2013mediated proliferation of Cd4+ and Cd8+ T cells","volume":"9","author":"Monti","year":"2009","journal-title":"Am J Transplant"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000396","article-title":"Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1\/2 trial","volume":"98","author":"Maffi","year":"2014","journal-title":"Transplantation"},{"key":"B262","doi-asserted-by":"publisher","first-page":"11367","DOI":"10.3389\/ti.2023.11367","article-title":"A multi-modal approach to islet and pancreas transplantation with calcineurin-sparing immunosuppression maintains long-term insulin independence in patients with type I diabetes","volume":"36","author":"Wisel","year":"2023","journal-title":"Transplant Int"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2008.04.025","article-title":"New directions for induction immunosuppression strategy in solid organ transplantation","volume":"197","author":"Hawksworth","year":"2009","journal-title":"Am J Surg"},{"key":"B264","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.tp.0000234905.56926.7f","article-title":"Induction immunosuppression","volume":"82","author":"Kirk","year":"2006","journal-title":"Transplantation"},{"key":"B265","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11338-y","article-title":"Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes","volume":"10","author":"Singh","year":"2019","journal-title":"Nat Commun"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/382518","article-title":"Exenatide pretreatment improved graft function in nonhuman primate islet recipients compared to treatment after transplant only","volume":"2012","author":"Buss","year":"2012","journal-title":"J Transplant"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0138","article-title":"Rapamycin monotherapy in patients with type 1 diabetes modifies Cd4+ Cd25+ Foxp3+ Regulatory T-cells","volume":"57","author":"Monti","year":"2008","journal-title":"Diabetes"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.4161\/isl.1.1.8881","article-title":"Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans","volume":"1","author":"Melzi","year":"2009","journal-title":"Islets"},{"key":"B269","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4239\/wjd.v13.i10.835","article-title":"New therapeutic approaches for type 1 diabetes: disease-modifying therapies","volume":"13","author":"Nagy","year":"2022","journal-title":"World J Diabetes"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-Cd3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"New Engl J Med"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78492","article-title":"Anti-thymocyte globulin\/G-csf treatment preserves B Cell function in patients with established type 1 diabetes","volume":"125","author":"Haller","year":"2015","journal-title":"J Clin Invest"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1dal study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1172\/jci81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J Clin Invest"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"New Engl J Med"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006136","article-title":"Golimumab and beta-cell function in youth with new-onset type 1 diabetes","volume":"383","author":"Quattrin","year":"2020","journal-title":"New Engl J Med"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0054","article-title":"Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study","volume":"32","author":"Mastrandrea","year":"2009","journal-title":"Diabetes Care"},{"key":"B278","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1159\/000524866","article-title":"Recent advances in immune-based therapies for type 1 diabetes","author":"Smigoc Schweiger","year":"2022","journal-title":"Hormone Res Paediatrics"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose il-2 and treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60023-9","article-title":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","volume":"381","author":"Moran","year":"2013","journal-title":"Lancet"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00019-X","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of B-cell function in adults with recent-onset type 1 diabetes: A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"von Herrath","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00139-X","article-title":"Imatinib therapy for patients with recent-onset type 1 diabetes: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Gitelman","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055466","article-title":"Foxp3+ Regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation","volume":"13","author":"Sanders","year":"2022","journal-title":"Front Immunol"},{"key":"B284","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Trans Med"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0038","article-title":"Administration of Cd4+ Cd25highcd127\u2013 regulatory T cells preserves B-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1111\/tri.14163","article-title":"Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation","volume":"34","author":"Bergstr\u00f6m","year":"2021","journal-title":"Transplant Int"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040139","article-title":"In vitro\u2013expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"key":"B289","doi-asserted-by":"publisher","first-page":"104220","DOI":"10.1016\/j.cellimm.2020.104220","article-title":"Building a car-treg: going from the basic to the luxury model","volume":"358","author":"Rosado-Sanchez","year":"2020","journal-title":"Cell Immunol"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052302","article-title":"Synthetic immunology: hacking immune cells to expand their therapeutic capabilities","volume":"35","author":"Roybal","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777788","article-title":"Using the T cell receptor as a biomarker in type 1 diabetes","volume":"12","author":"Nakayama","year":"2021","journal-title":"Front Immunol"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1015855","article-title":"Characterizing T cell responses to enzymatically modified beta cell neo-epitopes","volume":"13","author":"Nguyen","year":"2023","journal-title":"Front Immunol"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01689","article-title":"Tcr redirected T cells for cancer treatment: achievements, hurdles, and goals","volume":"11","author":"Manfredi","year":"2020","journal-title":"Front Immunol"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T cells using orthogonal Il-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005582","article-title":"Membrane-bound Il-2 improves the expansion, survival, and phenotype of car tregs and confers resistance to calcineurin inhibitors","volume":"13","author":"Kremer","year":"2022","journal-title":"Front Immunol"},{"key":"B296","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large-scale in vitro expansion of polyclonal human Cd4+ Cd25high regulatory T cells","volume":"104","author":"Hoffmann","year":"2004","journal-title":"Blood"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201286","article-title":"Il-7 abrogates suppressive activity of human Cd4+ Cd25+ Foxp3+ Regulatory T cells and allows expansion of alloreactive and autoreactive T cells","volume":"189","author":"Heninger","year":"2012","journal-title":"J Immunol"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13690","article-title":"Interleukin-7 improves the fitness of regulatory T cells for adoptive transfer","volume":"170","author":"Cosorich","year":"2023","journal-title":"Immunology"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.59","article-title":"Hla engineering of human pluripotent stem cells","volume":"21","author":"Riolobos","year":"2013","journal-title":"Mol Ther"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0049","article-title":"Targeted disruption of the B 2-microglobulin gene minimizes the immunogenicity of human embryonic stem cells","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Trans Med"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3860","article-title":"Hla-E-expressing pluripotent stem cells escape allogeneic responses and lysis by Nk cells","volume":"35","author":"Gornalusse","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"B303","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13287-022-03233-z","article-title":"Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity","volume":"14","author":"Chen","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.9.5199","article-title":"Hla-E is a major ligand for the natural killer inhibitory receptor Cd94\/Nkg2a","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.05.001","article-title":"The expanding role of murine class Ib Mhc in the development and activation of natural killer cells","volume":"115","author":"Goodall","year":"2019","journal-title":"Mol\u00a0Immunol"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1217809","article-title":"Co-expression of Hla-E and Hla-G on genetically modified porcine endothelial cells attenuates human Nk cell-mediated degranulation","volume":"14","author":"Cross-Najafi","year":"2023","journal-title":"Front Immunol"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of Hla-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5288.792","article-title":"Protection from natural killer cell-mediated lysis by Hla-G expression on target cells","volume":"274","author":"Pazmany","year":"1996","journal-title":"Science"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3269","article-title":"Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted B2m-Hla-G fusion proteins","volume":"38","author":"Shi","year":"2020","journal-title":"Stem Cells"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111423","article-title":"Engineering of immune checkpoints B7-H3 and Cd155 enhances immune compatibility of Mhc-I\u2013\/\u2013 Ipscs for B Cell replacement","volume":"40","author":"Chimienti","year":"2022","journal-title":"Cell Rep"},{"key":"B312","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-015-0051-6","article-title":"Functional disruption of human leukocyte antigen ii in human embryonic stem cell","volume":"48","author":"Chen","year":"2015","journal-title":"Biol Res"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the Ctla-4 and Pd-1 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol Rev"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.11.014","article-title":"An effective approach to prevent immune rejection of human esc-derived allografts","volume":"14","author":"Rong","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1038\/nri701","article-title":"The enemy within: keeping self-reactive T cells at bay in the periphery","volume":"2","author":"Walker","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.05.046","article-title":"Cd47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg5794","article-title":"Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice","volume":"15","author":"Hu","year":"2023","journal-title":"Sci Trans Med"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"Gcn2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B320","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17162","article-title":"Islet allografts expressing a pd-L1 and ido fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression","volume":"22","author":"Paul","year":"2022","journal-title":"Am J Transplant"},{"key":"B321","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41587-023-01784-x","article-title":"Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques","author":"Hu","year":"2023","journal-title":"Nat Biotechnol"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100879","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","author":"Gerace","year":"2023","journal-title":"Cell Rep Med"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00095","article-title":"Improving the safety of cell therapy with the Tk-suicide gene","volume":"6","author":"Greco","year":"2015","journal-title":"Front Pharmacol"},{"key":"B324","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.omtm.2022.05.011","article-title":"Targeted biallelic integration of an inducible caspase 9 suicide gene in Ipscs for safer therapies","volume":"26","author":"Wunderlich","year":"2022","journal-title":"Mol Therapy-Methods Clin Dev"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2022.1050507","article-title":"Crispr nuclease off-target activity and mitigation strategies","volume":"4","author":"Wienert","year":"2022","journal-title":"Front Genome Editing"},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.280","article-title":"Delivery technologies for genome editing","volume":"16","author":"Yin","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.08.029","article-title":"Delivery and therapeutic applications of gene editing technologies Zfns, Talens, and Crispr\/Cas9","volume":"494","author":"LaFountaine","year":"2015","journal-title":"Int J pharmaceutics"},{"key":"B328","doi-asserted-by":"publisher","first-page":"10555","DOI":"10.3389\/ti.2022.10555","article-title":"Bioengineering the vascularized endocrine pancreas: A fine-tuned interplay between vascularization, extracellular-matrix-based scaffold architecture, and insulin-producing cells","volume":"35","author":"Pignatelli","year":"2022","journal-title":"Transplant Int"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.05.051","article-title":"Engineering the vasculature for islet transplantation","volume":"95","author":"Bowers","year":"2019","journal-title":"Acta biomaterialia"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.097","article-title":"Perfusion decellularization of whole organs","volume":"9","author":"Guyette","year":"2014","journal-title":"Nat Protoc"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202301673","article-title":"Shaping synthetic multicellular and complex multimaterial tissues via embedded extrusion-volumetric printing of microgels","volume":"35","author":"Ribezzi","year":"2023","journal-title":"Adv Mater"},{"key":"B332","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biomaterials.2019.01.035","article-title":"Biofabrication of a vascularized islet organ for type 1 diabetes","volume":"199","author":"Citro","year":"2019","journal-title":"Biomaterials"},{"key":"B333","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41467-023-36582-1","article-title":"Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes","volume":"14","author":"Citro","year":"2023","journal-title":"Nat Commun"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2022.04.002","article-title":"Biomaterials to enhance stem cell transplantation","volume":"29","author":"Kharbikar","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B335","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically modified porcine-to-human cardiac xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"New Engl J Med"},{"key":"B336","doi-asserted-by":"publisher","DOI":"10.1089\/ten.teb.2007.0332","article-title":"Cell encapsulation in biodegradable hydrogels for\u00a0tissue engineering applications","volume":"14","author":"Nicodemus","year":"2008","journal-title":"Tissue Eng Part B: Rev"},{"key":"B337","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-319-18603-0_12","article-title":"Cell surface engineering for regulation of immune reactions in cell therapy","volume":"865","author":"Teramura","year":"2015","journal-title":"Immune Responses to Biosurfaces: Mech Ther Interventions"},{"key":"B338","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actbio.2021.05.039","article-title":"Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in type 1 diabetes","volume":"133","author":"Samojlik","year":"2021","journal-title":"Acta biomaterialia"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-018-0099-0","article-title":"Local immunomodulation with fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance","volume":"17","author":"Headen","year":"2018","journal-title":"Nat materials"},{"key":"B340","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.2c12939","article-title":"Fas ligand-modified scaffolds protect stem cell derived B-cells by modulating immune cell numbers and polarization","author":"Li","year":"2022","journal-title":"ACS Appl Materials Interfaces"},{"key":"B341","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1038\/s41467-022-33760-5","article-title":"A predictive computational platform for optimizing the design of bioartificial pancreas devices","volume":"13","author":"Ernst","year":"2022","journal-title":"Nat Commun"},{"key":"B342","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/biomimetics8050442","article-title":"Artificial intelligence in regenerative medicine: applications and implications","volume":"8","author":"Nosrati","year":"2023","journal-title":"Biomimetics"},{"key":"B343","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4252\/wjsc.v13.i6.521","article-title":"Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine","volume":"13","author":"Mukherjee","year":"2021","journal-title":"World J Stem Cells"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1323439\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T10:57:46Z","timestamp":1700737066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1323439\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":343,"alternative-id":["10.3389\/fimmu.2023.1323439"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1323439","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1323439"}}